BIOG-B:STO
BioGaia AB
SEKÂ 111.50
arrow_downward
-1.68%(-1.90) 1D
Sep 3, 5:29:36 PM GMT+2 · SEK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIOG-B...
Open
SEKÂ 113.40
High
SEKÂ 114.90
Low
SEKÂ 111.20
Mkt. cap
11.17B
Avg. vol.
149.04K
Volume
91.50K
52-wk high
SEKÂ 136.30
52-wk low
SEKÂ 96.20
Shares outstanding
98.50M
No. of employees
251
Open
SEKÂ 113.40
High
SEKÂ 114.90
Low
SEKÂ 111.20
Mkt. cap
11.17B
Avg. vol.
149.04K
Volume
91.50K
52-wk high
SEKÂ 136.30
52-wk low
SEKÂ 96.20
Shares outstanding
98.50M
No. of employees
251
Profile
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
About BioGaia AB